Abstract CT011: First-in-human Phase I study of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase-1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid malignancies
Authors: Kyriakos Papadopoulos, Paul Eder, Sarina A. Piha-Paul, Claude Gimmi, Elizabeth Hussey, Sen Zhang, Lu Li, Christina Habermehl, Aung Naing